neuropathy haematopoietic stem cell niche essential myeloproliferative neoplasms 
myeloproliferative neoplasms mpns diseases caused mutations haematopoietic stem cell hsc compartment mpn patients common acquired mutation janus kinase jak2 gene hscs1- renders kinase constitutively active leading uncontrolled cell expansion bone marrow microenvironment might contribute clinical outcomes common event previously showed bone marrow nestin+ mesenchymal stem cells mscs innervated sympathetic nerve fibres regulate normal hscs56 demonstrate abrogation regulatory circuit essential mpn pathogenesis sympathetic nerve fibres supporting schwann cells nestin+ mscs consistently reduced bone marrow mpn patients mice expressing human jak2v617f mutation hscs unexpectedly msc reduction due differentiation caused bone marrow neural damage schwann cell death triggered interleukin- beta produced mutant hscs turn vivo depletion nestin+ cells production cxcl12 expanded mutant hsc number accelerated mpn progression contrast administration neuroprotective sympathomimetic drugs prevented mutant hsc expansion treatment beta3-adrenergic agonists restored sympathetic regulation nestin+ mscs56 prevented loss cells blocked mpn progression indirectly reducing number leukaemic stem cells results demonstrate mutant-hsc-driven niche damage critically contributes disease manifestation mpn identify niche-forming mscs neural regulation promising therapeutic targets 
